CENCORA INC (COR) Stock Price & Overview

NYSE:COR • US03073E1055

Current stock price

349.95 USD
-2.7 (-0.77%)
At close:
348.21 USD
-1.74 (-0.5%)
After Hours:

The current stock price of COR is 349.95 USD. Today COR is down by -0.77%. In the past month the price decreased by -0.32%. In the past year, price increased by 35.6%.

COR Key Statistics

52-Week Range255.76 - 377.54
Current COR stock price positioned within its 52-week range.
1-Month Range346.92 - 376.92
Current COR stock price positioned within its 1-month range.
Market Cap
68.076B
P/E
21.42
Fwd P/E
17.59
EPS (TTM)
16.34
Dividend Yield
0.68%

COR Stock Performance

Today
-0.77%
1 Week
-2.37%
1 Month
-0.32%
3 Months
+1.14%
Longer-term
6 Months +15.68%
1 Year +35.60%
2 Years +44.02%
3 Years N/A
5 Years N/A
10 Years N/A

COR Stock Chart

CENCORA INC / COR Daily stock chart

COR Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to COR. When comparing the yearly performance of all stocks, COR is one of the better performing stocks in the market, outperforming 81.77% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

COR Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to COR. COR has only an average score on both its financial health and profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

COR Earnings

On February 4, 2026 COR reported an EPS of 4.08 and a revenue of 85.93B. The company beat EPS expectations (0.03% surprise) and missed revenue expectations (-1.1% surprise).

Next Earnings DateMay 5, 2026
Last Earnings DateFeb 4, 2026
PeriodQ1 / 2026
EPS Reported$4.08
Revenue Reported85.932B
EPS Surprise 0.03%
Revenue Surprise -1.10%

COR Forecast & Estimates

22 analysts have analysed COR and the average price target is 407.01 USD. This implies a price increase of 16.31% is expected in the next year compared to the current price of 349.95.

For the next year, analysts expect an EPS growth of 11.29% and a revenue growth 7.99% for COR


Analysts
Analysts82.73
Price Target407.01 (16.31%)
EPS Next Y11.29%
Revenue Next Year7.99%

COR Groups

Sector & Classification

COR Financial Highlights

Over the last trailing twelve months COR reported a non-GAAP Earnings per Share(EPS) of 16.34. The EPS increased by 14.99% compared to the year before.


Income Statements
Revenue(TTM)325.78B
Net Income(TTM)1.63B
Industry RankSector Rank
PM (TTM) 0.5%
ROA 2.07%
ROE 85.16%
Debt/Equity 3.97
Chartmill High Growth Momentum
EPS Q2Q%9.38%
Sales Q2Q%5.45%
EPS 1Y (TTM)14.99%
Revenue 1Y (TTM)7.45%

COR Ownership

Ownership
Inst Owners96.15%
Shares194.53M
Float184.86M
Ins Owners0.09%
Short Float %2.88%
Short Ratio4.45

About COR

Company Profile

COR logo image Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 51,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.

Company Info

IPO: 1996-05-28

CENCORA INC

1 West First Avenue

Conshohocken PENNSYLVANIA 80202 US

CEO: Paul E. Szurek

Employees: 51000

COR Company Website

COR Investor Relations

Phone: 13026587581

CENCORA INC / COR FAQ

What does COR do?

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 51,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.


What is the current price of COR stock?

The current stock price of COR is 349.95 USD. The price decreased by -0.77% in the last trading session.


Does COR stock pay dividends?

CENCORA INC (COR) has a dividend yield of 0.68%. The yearly dividend amount is currently 2.25.


What is the ChartMill rating of CENCORA INC stock?

COR has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What is the Price/Earnings (PE) ratio of CENCORA INC (COR)?

The PE ratio for CENCORA INC (COR) is 21.42. This is based on the reported non-GAAP earnings per share of 16.34 and the current share price of 349.95 USD.


Can you provide the growth outlook for CENCORA INC?

The Revenue of CENCORA INC (COR) is expected to grow by 7.99% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


Can you provide the ownership details for COR stock?

You can find the ownership structure of CENCORA INC (COR) on the Ownership tab.